A. Soudi Et Al. , "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor," Pharmaceuticals , vol.17, no.5, 2024
Soudi, A. Et Al. 2024. Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals , vol.17, no.5 .
Soudi, A., Bender, O., ÇELİK, İ., El-Hafeez, A. A. A., Dogan, R., ATALAY, A., ... Elkaeed, E. B.(2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals , vol.17, no.5.
Soudi, Aya Et Al. "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor," Pharmaceuticals , vol.17, no.5, 2024
Soudi, Aya Et Al. "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor." Pharmaceuticals , vol.17, no.5, 2024
Soudi, A. Et Al. (2024) . "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor." Pharmaceuticals , vol.17, no.5.
@article{article, author={Aya Soudi Et Al. }, title={Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor}, journal={Pharmaceuticals}, year=2024}